JP2012092110A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092110A5
JP2012092110A5 JP2011256721A JP2011256721A JP2012092110A5 JP 2012092110 A5 JP2012092110 A5 JP 2012092110A5 JP 2011256721 A JP2011256721 A JP 2011256721A JP 2011256721 A JP2011256721 A JP 2011256721A JP 2012092110 A5 JP2012092110 A5 JP 2012092110A5
Authority
JP
Japan
Prior art keywords
cancer
use according
treatment
subject
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011256721A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092110A (ja
JP5421340B2 (ja
Filing date
Publication date
Priority claimed from MYPI20003987A external-priority patent/MY138883A/en
Application filed filed Critical
Publication of JP2012092110A publication Critical patent/JP2012092110A/ja
Publication of JP2012092110A5 publication Critical patent/JP2012092110A5/ja
Application granted granted Critical
Publication of JP5421340B2 publication Critical patent/JP5421340B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011256721A 2000-08-29 2011-11-24 癌治療のためのアジア酸またはアジアチコサイドの使用。 Expired - Fee Related JP5421340B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20003987 2000-08-29
MYPI20003987A MY138883A (en) 2000-08-29 2000-08-29 Use of asiatic acid for treatment of cencer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002522878A Division JP2004507496A (ja) 2000-08-29 2001-02-14 癌治療のためのアジア酸またはアジアチコサイドの使用。

Publications (3)

Publication Number Publication Date
JP2012092110A JP2012092110A (ja) 2012-05-17
JP2012092110A5 true JP2012092110A5 (enExample) 2013-04-04
JP5421340B2 JP5421340B2 (ja) 2014-02-19

Family

ID=19749475

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002522878A Pending JP2004507496A (ja) 2000-08-29 2001-02-14 癌治療のためのアジア酸またはアジアチコサイドの使用。
JP2011256721A Expired - Fee Related JP5421340B2 (ja) 2000-08-29 2011-11-24 癌治療のためのアジア酸またはアジアチコサイドの使用。

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002522878A Pending JP2004507496A (ja) 2000-08-29 2001-02-14 癌治療のためのアジア酸またはアジアチコサイドの使用。

Country Status (9)

Country Link
US (1) US20040097463A1 (enExample)
EP (1) EP1313462B1 (enExample)
JP (2) JP2004507496A (enExample)
AT (1) ATE415962T1 (enExample)
AU (1) AU2001247968A1 (enExample)
DE (1) DE60136826D1 (enExample)
DK (1) DK1313462T3 (enExample)
MY (1) MY138883A (enExample)
WO (1) WO2002017904A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144312A1 (en) * 2001-10-30 2003-07-31 Schoenhard Grant L. Inhibitors of ABC drug transporters in multidrug resistant cancer cells
KR100571886B1 (ko) 2004-02-23 2006-04-17 학교법인 영남학원 아시아틱산을 포함하는 피부암 예방 또는 치료용 조성물
ES2368741T3 (es) * 2004-02-25 2011-11-21 Dana-Farber Cancer Institute, Inc. Inhibidores del receptor 1 del factor de crecimiento de tipo insulina para inhibir el crecimiento de células tumorales.
WO2006012015A2 (en) * 2004-06-29 2006-02-02 Oregon Health And Science University Methods and compositions for nerve regeneration
US20070010459A1 (en) * 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
US20090018146A1 (en) * 2005-01-27 2009-01-15 Research Development Corporation Combination Therapy with Triterpenoid Compounds and Proteasome Inhibitors
US8742167B2 (en) 2008-01-11 2014-06-03 Shanghai Institute Of Pharmaceutical Industry Therapeutic formulations based on asiatic acid and selected salts thereof
EP3062106B1 (en) 2008-04-16 2020-11-11 The Johns Hopkins University Method for determining androgen receptor variants in prostate cancer
WO2009148623A2 (en) 2008-06-05 2009-12-10 Stc.Unm Methods and related compositions for the treatment of cancer
JP6068980B2 (ja) 2009-12-21 2017-01-25 ピレリ・タイヤ・ソチエタ・ペル・アツィオーニ タイヤを構築するためのプロセスおよびプラント
AU2010354973B2 (en) 2010-06-10 2015-01-22 Indus Biotech Private Limited A method for preparation of highly pure asiaticoside composition from Centella asiatica and a method of use thereof
JP6091431B2 (ja) * 2011-01-31 2017-03-15 ルコラス−エム.ディー.リミテッド 医薬的使用
US20140194368A1 (en) * 2013-01-04 2014-07-10 Beech Tree Labs, Inc. Method of Treating Cancer by Administration of Low Levels of Heat Shock Protein 70 (HSP70)
RU2015137617A (ru) 2013-03-14 2017-04-18 Юниверсити Оф Мэриленд, Балтимор Офис Оф Текнолоджи Трансфер Агенты, подавляющие андрогенные рецепторы, и их применение
CN105283175A (zh) * 2013-05-03 2016-01-27 西莱克塔生物科技公司 用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子
KR20160058774A (ko) 2013-08-12 2016-05-25 토카이 파마슈티컬, 아이엔씨. 안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커
EP3146081B1 (en) 2014-05-19 2020-10-28 The Johns Hopkins University Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer
CA2959336A1 (en) * 2014-08-25 2016-03-03 The Johns Hopkins University Methods and compositions related to prostate cancer therapeutics
EP3124047A1 (en) * 2015-07-28 2017-02-01 Merz Pharma GmbH & Co. KGaA Pentacyclic triterpenoids for injection lipolysis
US20180228815A1 (en) * 2016-11-09 2018-08-16 The Chinese University Of Hong Kong Naringenin and asiatic acid combination treatment of cancers
JP7523909B2 (ja) 2017-03-11 2024-07-29 セレクタ バイオサイエンシーズ インコーポレーテッド 抗炎症剤および免疫抑制剤を含む合成ナノキャリアによる組み合わせ処置に関連する方法および組成物
WO2019200585A1 (en) * 2018-04-19 2019-10-24 The Chinese University Of Hong Kong Naringenin and asiatic acid combination treatment of cancers
WO2020078454A1 (en) * 2018-10-18 2020-04-23 Sinomab Bioscience Limited Method of modulating autoimmunity by disrupting cis‐ligand binding of siglec type antigens
CN109528735B (zh) * 2019-01-30 2021-03-12 中国药科大学 积雪草苷在制备治疗皮肤癌药物中的新用途
CN110200981A (zh) * 2019-06-06 2019-09-06 中国药科大学 五环三萜皂苷的医药用途及其药物组合物
US20240034788A1 (en) * 2020-08-20 2024-02-01 The Board Of Trustees Of The Leland Stanford Junior University Abscopal therapy for cancer
US20250275978A1 (en) * 2024-03-04 2025-09-04 Cardiff Oncology, Inc. Use of onvansertib as monotherapy and in combination with cetuximab in treating ras wild-type colorectal cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB923414A (en) * 1960-04-13 1963-04-10 Laroche Navarron Lab Therapeutic compositions comprising asiatic and arjunolic acids
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
EP0383171A3 (en) * 1989-02-11 1991-07-24 Hoechst Aktiengesellschaft 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
FR2714598B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition amincissante à deux types de liposomes pour traitement topique, son utilisation.
JPH08133952A (ja) * 1994-11-07 1996-05-28 Shiseido Co Ltd 皮膚外用剤
DE69705238T2 (de) * 1996-11-27 2002-04-18 Dong Kook Pharmaceutical Co., Ltd. Derivate der asiatica-saeure mit einem modifizierten a-ring
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
FR2763336B1 (fr) * 1997-05-14 1999-08-06 Lvmh Rech Esters de tocopherol et leurs utilisations en cosmetique et pharmacie
KR20070026646A (ko) * 2004-06-14 2007-03-08 조세르 비. 살라마 프롤린 또는 이의 유도체 및 항종양 항체를 함유하는 항암조성물

Similar Documents

Publication Publication Date Title
JP2012092110A5 (enExample)
JP2013525444A5 (enExample)
WO2014004902A3 (en) Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
BR112014003225A2 (pt) profármacos de treprostinil ligados a veículo
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
JO3091B1 (ar) مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
CO7240369A2 (es) Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso
CO6382125A2 (es) Inhibidores de proteína quinasa
BR112014000268A2 (pt) pirazolopiridinas com substituinte heteroarilo e utilização destas
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
WO2012117000A8 (en) 3-amino-pyridines as gpbar1 agonists
AR087107A1 (es) Compuesto inhibidor de la señalizacion de la trayectoria notch
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
MX2015003021A (es) Derivados de acido glicirretinico y metodos de uso de los mismos.
MX2013011124A (es) Compuestos para el tratamiento del sindrome metabolico.
ECSP12011703A (es) Composiciones farmacéuticas para el tratamiento del cáncer y otras enfermedades o trastornos
BR112014031091A2 (pt) Derivados de piperidina para agonista de gpr119
EP2585067A4 (en) COMPOUND FOR THE TREATMENT OF ENTEROVIRUS
CR20130693A (es) Composición farmacéutica ortalmológica tópica que contiene regorafenib
AR084832A1 (es) Derivado cristalino de oxazina
BR112014008783A2 (pt) compostos para o tratamento e profilaxia da doença causada por vírus sincicial respiratório
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso